## Abstract ## Objective Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy, and a duplication of the __Pmp22__ gene causes the most frequent subform CMT1A. Using a transgenic rat model of CMT1A, we tested the hypothesis that long‐term treatment with anti‐progesterone (Onapr
Neuroactive Steroid Levels in a Transgenic Rat Model of CMT1A Neuropathy
✍ Scribed by Donatella Caruso; Samuele Scurati; Ilaria Roglio; Lucilla Nobbio; Angelo Schenone; Roberto C Melcangi
- Publisher
- Humana Press Inc
- Year
- 2008
- Tongue
- English
- Weight
- 109 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0895-8696
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The recent development of a rat model of amyotrophic lateral sclerosis (ALS) in which the rats harbor a mutated human SOD1 (G93A) gene has greatly expanded the range of potential experiments, because the rats' large size permits biochemical analyses and therapeutic trials, such as the intrathecal in
## Abstract The main objective of the present study was to develop an alternative singly‐transgenic (tg) hAPP model where amyloid deposition will occur at an earlier age. For this purpose, we generated lines of tg mice expressing hAPP751 cDNA containing the London (V717I) and Swedish (K670M/N671L)